Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice

Neurotoxicology and Teratology

Volumn 18, Issue 5, 1996, Pages 603-606

  Dluzen, Dean E ^a   McDermott, Janet L ^a,b   Liu, Binjun ^a  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b Edwin Shaw Hospital   (United States)

Author keywords

Corpus striatum; Gonadectomy; Mice; Nigrostriatal; Sex differences

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; ESTRADIOL; ESTROGEN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; FEMALE; GONADECTOMY; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 0030250515     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/0892-0362(96)00086-4     Document Type: Article

References (23)

1. 2 dopamine receptor binding. Brain Res. 637:163-172; 1994.
2. 2. Bedard, P. J.; Langelier, P.; Villeneuve, A. Oestrogens and extrapyramidal system. Lancet ii:1367-1368; 1977.
3. 3. Chen, X. L.; Li, R.; Gupta, M. Estrogen may protect females from parkinson's disease. Soc. Neurosci. Abstr. 21:1252; 1995.
4. 4. Cleeter, M. W. J.; Cooper, J. M.; Schapira, A. H. V. Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: Evidence for free radical involvement. J. Neurochem. 58:786-789; 1992.
5. 5. Del Zompo, M.; Piccardi, M.; Ruiu, M.; Quartu, M.; Vaccari, A. Selective MPP+ uptake into synaptic dopamine vesicles possible involvement in MPTP neurotoxicity. Br. J. Pharmacol. 109:411-414; 1993.
6. 6. Diamond, S. G.; Markham, C. H.; Hoehn, M. M.; McDowell, F. H.; Meunter, M. D. An examination of male-female differences in the progression of Parkinson's disease, Neurology 40:763-766; 1990.
7. 7. Disshon, K.; Dluzen, D. Estrogen as a neuroprotectant against MPTP-induced neurotoxicity: 2 Effects upon corpus striatal dopamine release. Int. Soc. Psychoneuroendocrinol. Abstr. 26:29; 1995.
8. 8. Dluzen, D. E. Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system in male C57/ Bl mice. Brain Res. 715:113-118; 1996.
9. 9. Dluzen, D. E.; Jain, R.; Liu, B. Modulatory effects of testosterone on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J. Neurochem. 62:94-101; 1994.
10. 10. Dluzen, D. E.; McDermott, J. L.; Liu, B. Estrogen alters MPTP-induced neurotoxicity in female mice: Effects on striatal dopamine concentrations and release. J. Neurochem. 66:658-666; 1996.
11. 11. Gerlach, M.; Riederer, P.; Przuntek, H.; Youdim, M. B. H. MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease. Eur. J. Pharmacol. 208:273-286; 1991.
12. 12. Ghosh, D.; Ray, A. K. Subcellular action of estradiol-17 beta in a freshwater prawn Macrobrachium rosenbergii. Gen. Comp. Endocrinol. 90:274-281; 1993.
13. 13. Giovanni, A.; Sieber, B-A.; Heikkila, R. E.; Sonsalla, P. K. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3.6-tetrahydropyridine. Part 1: Systemic administration. J. Pharmacol. Exp. Ther. 200:1000-1007; 1994.
14. 14. Glazer, W. M.; Naftolin, F.; Moore, D. C.; Bowers, M. B.; MacLusky, N. J. The relationship of circulating estradiol to tardive dyskinesia in men and postmenopausal women. Psychoneuroendocrinology 8:429-443; 1983.
15. 15. Gomez-Mancilla, B.; Bedard, P. J. Effect of estrogen and progesterone on L-DOPA induced dyskinesia in MPTP-treated monkeys. Neurosci. Lett. 135:129-132; 1992.
16. 16. Kitayama, S.; Wang, J-B.; Uhl, G. R. Dopamine transporter mutants selectively enhance MPP+transport. Synapse 15:58-62; 1993.
17. 17. McDermott, J. L.; Liu, B.; Dluzen, D. E. Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice. Exp. Neurol. 125:306-311; 1994.
18. 18. Michel, M. C.; Rother, A.; Hiemke, C.; Ghraf, R. Inhibition of synaptosomal high-affinity uptake of dopamine and serotonin by estrogen agonists and antagonists. Biochem. Pharmacol. 36:3175-3180; 1987.
19. 19. Ramirez, V. D. Hormones and striatal dopamine activity: A novel neuroendocrine model. In: Bhatnagar, A. S., ed. The anterior pituitary gland. New York: Raven Press; 1983:97-1045.
20. 20. Ruiz-Larrea, M. B.; Leal, A. M.; Liza, M.; Lacort, M.; deGroot, H. Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids 59:383-388; 1994.
21. 21. Sziraki, I.; Kardos, V.; Patthy, M.; Patfalusi, M.; Budai, G. Methamphetamine protects against MPTP neurotoxicity in C57B1 mice. Eur.J. Pharmacol. 251:311-314; 1994.
22. 22. Unzeta, M.; Baron, S.; Perez, V.; Ambrosio, S.; Mahy, N. Sex related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahyrdo-pyridine treatment may be related to differences in monoamine oxidase B. Neurosci. Lett. 176:235-238; 1994.
23. 23. van Hartesveldt, C.; Joyce, J. N. Effects of estrogen on the basal ganglia. Neurosci. Biobehav. Rev. 10:1-14; 1986.